NutritionRx · GLP-1 Nutrition Support · Boston

For patients on GLP-1 medications

You started a GLP-1. Here's what they didn't tell you.

Alexis Beck, MPH, RD, LDN · Twenty-five years

The medication is real. The weight loss is real. But twenty-five to forty percent of GLP-1 weight loss is lean muscle mass without nutritional intervention. That, plus the micronutrient gaps and the underlying biology the prescription does not address, is the work NutritionRx does.

By application only. Coordinated alongside your prescribing physician.

  • Massachusetts License LDN #885NU
  • Obesity Medicine Association
  • Boston Globe column · 15 yrs
  • 4.9 ★ Zocdoc

What works

The medication is real.

Semaglutide and tirzepatide produce clinically meaningful weight loss for most patients. The trials show it. The patients in this practice show it. Alexis is not anti-medication.

GLP-1 receptor agonists work by suppressing appetite, slowing gastric emptying, and improving glycemic control. For patients who meet the clinical criteria, they can be the right tool. Ozempic, Wegovy, Mounjaro, and Zepbound have all reshaped what is possible in obesity medicine over the last several years.

The medication is one tool inside a clinical plan. It is not the plan itself. The piece of the picture almost no patient is told about, before they start, is what happens around the prescription.

What's missing

What the prescription does not include.

What the medication will not do for you, and what is missing from a typical fifteen-minute prescriber appointment.

01

Lean mass preservation

25 to 40 percent of GLP-1 weight loss is lean muscle mass without nutritional and resistance-training intervention.

02

Micronutrient adequacy

Reduced food volume on a GLP-1 means reduced micronutrient volume. B12, iron, magnesium, vitamin D, and fiber are the patterns Alexis sees most.

03

Underlying biology

The drivers that put the weight on in the first place are not all addressed by the medication. GLP-1s help appetite and glycemic signaling and improve some inflammatory markers, but they don't directly treat sleep, cortisol load, sex-hormone shifts, or the visceral-adiposity inflammation tied to them.

What NutritionRx does

The clinical nutrition support your prescription does not include.

NutritionRx does not prescribe GLP-1 medications. Alexis works alongside your prescriber. The work is what the prescription leaves out.

  • 01

    Intake and lab review

    Alexis pulls your existing labs, your prescriber's notes, and your medication history. She reads them against your current dose, your weight trajectory, and your symptoms. The plan is built from a real clinical picture, not a pamphlet.

  • 02

    Protein and resistance-training integration

    Daily protein floor sized to your body weight and dose, distributed across meals, with leucine adequacy. Resistance-training cadence coordinated with your physician's clearance.

  • 03

    Targeted micronutrient supplementation

    Labs read against your intake. Supplementation mapped to your specific gaps, not a generic multivitamin. Re-tested at intervals as your dose changes.

  • 04

    Coordinated with your prescriber

    Alexis sends notes, shares lab review, and coordinates dose-adjustment windows with nutrition load. Your physician stays the prescriber. She is the clinical nutrition arm of the team.

  • 05

    Discontinuation support

    Most patients eventually come off the medication. The regain curve after stopping a GLP-1 is well documented when the underlying biology has not been addressed. Alexis supports the transition so the work holds, not just the prescription window.

“Most patients are told what the medication will do. Almost no one is told what it won’t.”

Alexis Beck, MPH, RD, LDN

Sustained Results

The Majority Of My Patients
Keep It Off.

Long-term outcomes are what this practice was built for. Not the loss, the maintenance.

Individual results vary.

From her patients

In their words.

A highly intelligent and intuitive clinician whose therapeutic techniques are leaps and bounds ahead of her peers.
Long-time patient Verified review

★★★★★

She gets it. I have a treatment plan that makes sense for the first time.
A NutritionRx patient Bulimia and obesity

★★★★★

Alexis is an excellent resource and helps identify the root of nutritional patterns.
Petey M. Trainer recommended

★★★★★

Common questions

Before you ask.

Do you prescribe GLP-1 medications?

No. Alexis is a Registered Dietitian, not a physician. Your prescriber stays the prescriber. She is the clinical nutrition arm of the team.

Will you work with my prescribing physician?

Yes. Alexis sends clinical notes, shares lab review, and coordinates dose-adjustment windows with nutrition load. Most of her patients have an endocrinologist, primary-care physician, cardiologist, or bariatric specialist already on the case.

What if I am planning to come off the medication?

Discontinuation is its own clinical event. The regain curve after stopping a GLP-1 is well documented when the underlying biology and behaviors have not been addressed. Alexis supports the transition, not just the active prescription.

How is this different from a coach who texts me reminders?

This is clinical nutrition therapy, not behavior coaching. The work begins with an intake, a lab review, and a clinical formulation read against your medication. Sessions are sixty minutes. Continuity is multi-year. The same standard as any other medical specialty.

Is this insurance-billed?

No. NutritionRx is private-pay only. Most patients work with Alexis for two and a half to five years. She accepts patients by application.

View sources cited on this page
  1. Lean mass loss on GLP-1 medications Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 2021 (STEP-1 trial). Body composition sub-analyses in subsequent semaglutide and tirzepatide trials confirmed the lean-mass loss range.
  2. Protein and resistance-training requirements during weight loss Jäger R et al. International Society of Sports Nutrition Position Stand: Protein and Exercise. Journal of the International Society of Sports Nutrition, 2017.
  3. Per-meal leucine threshold for muscle protein synthesis Phillips SM, Chevalier S, Leidy HJ. Protein "requirements" beyond the RDA. Applied Physiology, Nutrition, and Metabolism, 2016.
  4. Obesity classified as a chronic medical disease American Medical Association, House of Delegates Resolution 420 (A-13), adopted 2013.
  5. Long-term weight loss success benchmark Wing RR, Phelan S. Long-term weight loss maintenance. American Journal of Clinical Nutrition, 2005, 82(1 Suppl):222S-225S. Source for the general-literature long-term weight-loss success rate cited on this site (approximately 20%).
  6. Regain after stopping GLP-1 medication Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022. Source for the regain-after-discontinuation claim cited on this page.
  7. NutritionRx outcome statistics Internal clinical outcomes data, 20+ years of practice. Individual results vary. NutritionRx outcomes are not third-party-audited; the figure is provided as the practice's stated record.

You started the medication.
Now do the work that makes it last.

Qualification takes less than a minute. Alexis reviews every submission personally and tells you whether NutritionRx is the right fit, even if it isn't.

Reserve a Consultation →